$BHC
Bausch Health Companies Inc.

2013 Q2 Form 10-Q Financial Statement

#000088559013000067 Filed on August 07, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2 2012 Q1
Revenue $1.096B $820.1M $856.1M
YoY Change 33.61% 34.57% 51.52%
Cost Of Revenue $283.2M $192.9M $224.2M
YoY Change 46.79% 11.33% 10.33%
Gross Profit $812.5M $627.2M $631.9M
YoY Change 29.55% 43.81% 74.66%
Gross Profit Margin 74.15% 76.47% 73.81%
Selling, General & Admin $257.3M $185.4M $177.3M
YoY Change 38.75% 23.87% 27.09%
% of Gross Profit 31.67% 29.57% 28.06%
Research & Development $24.50M $17.71M $22.01M
YoY Change 38.33% -0.5% 60.63%
% of Gross Profit 3.02% 2.82% 3.48%
Depreciation & Amortization $317.9M $221.8M $215.6M
YoY Change 43.33% 81.36% 69.76%
% of Gross Profit 39.13% 35.37% 34.12%
Operating Expenses $281.8M $203.2M $199.3M
YoY Change 38.71% -28.06% -24.85%
Operating Profit $141.5M $86.81M $61.50M
YoY Change 63.0% -43.52% -36.34%
Interest Expense -$181.9M -$103.9M -$74.50M
YoY Change 75.07% 73.17% 17.51%
% of Operating Profit -128.55% -119.69% -121.15%
Other Income/Expense, Net
YoY Change
Pretax Income -$40.40M -$17.06M -$13.18M
YoY Change 136.85% -139.03% -525.19%
Income Tax -$51.20M $4.550M -$260.0K
% Of Pretax Income
Net Earnings $10.80M $231.7M $178.7M
YoY Change -95.34% 310.87% 2649.08%
Net Earnings / Revenue 0.99% 28.26% 20.87%
Basic Earnings Per Share $0.04 -$0.07
Diluted Earnings Per Share $0.03 -$0.07 -$41.91K
COMMON SHARES
Basic Shares Outstanding 308.1M shares 304.8M shares 307.8M shares
Diluted Shares Outstanding 314.4M shares 304.8M shares 307.8M shares

Balance Sheet

Concept 2013 Q2 2012 Q2 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.539B $395.0M $332.0M
YoY Change 542.78% 63.22% -18.23%
Cash & Equivalents $2.539B $395.3M $330.5M
Short-Term Investments $0.00 $1.000M
Other Short-Term Assets $368.0M $235.0M $213.0M
YoY Change 56.6% 115.6% 77.5%
Inventory $497.1M $389.0M $374.0M
Prepaid Expenses
Receivables $1.127B $611.0M $614.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.532B $1.630B $1.532B
YoY Change 178.04% 55.83% 20.16%
LONG-TERM ASSETS
Property, Plant & Equipment $441.0M $409.0M $427.0M
YoY Change 7.82% 28.21% 38.64%
Goodwill $5.278B
YoY Change
Intangibles $9.290B
YoY Change
Long-Term Investments
YoY Change
Other Assets $199.4M $134.0M $122.0M
YoY Change 48.83% -0.74% -12.86%
Total Long-Term Assets $15.25B $12.39B $12.09B
YoY Change 23.09% 14.91% 16.09%
TOTAL ASSETS
Total Short-Term Assets $4.532B $1.630B $1.532B
Total Long-Term Assets $15.25B $12.39B $12.09B
Total Assets $19.78B $14.02B $13.62B
YoY Change 41.1% 18.53% 16.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $284.5M $156.0M $156.0M
YoY Change 82.4% 22.83% 34.48%
Accrued Expenses $1.035B $601.0M $543.0M
YoY Change 72.21% 44.47% 9.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $346.9M $195.0M $145.0M
YoY Change 77.88% 983.33% 752.94%
Total Short-Term Liabilities $1.762B $1.049B $958.0M
YoY Change 67.95% 37.66% 44.93%
LONG-TERM LIABILITIES
Long-Term Debt $10.45B $7.356B $6.851B
YoY Change 42.02% 62.42% 45.8%
Other Long-Term Liabilities $161.7M $690.0M $600.0M
YoY Change -76.56% 11.29% 74.93%
Total Long-Term Liabilities $10.61B $8.046B $7.451B
YoY Change 31.85% 56.26% 47.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.762B $1.049B $958.0M
Total Long-Term Liabilities $10.61B $8.046B $7.451B
Total Liabilities $14.08B $10.32B $9.543B
YoY Change 36.38% 44.15% 36.74%
SHAREHOLDERS EQUITY
Retained Earnings -$2.429B
YoY Change
Common Stock $8.475B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.703B $3.695B $4.076B
YoY Change
Total Liabilities & Shareholders Equity $19.78B $14.02B $13.62B
YoY Change 41.1% 18.53% 16.53%

Cashflow Statement

Concept 2013 Q2 2012 Q2 2012 Q1
OPERATING ACTIVITIES
Net Income $10.80M $231.7M $178.7M
YoY Change -95.34% 310.87% 2649.08%
Depreciation, Depletion And Amortization $317.9M $221.8M $215.6M
YoY Change 43.33% 81.36% 69.76%
Cash From Operating Activities $305.1M $254.6M $167.2M
YoY Change 19.84% 33.51% 93.74%
INVESTING ACTIVITIES
Capital Expenditures $12.80M $13.60M $11.12M
YoY Change -5.89% -166.35% -103.43%
Acquisitions $513.4M $454.0M $272.8M
YoY Change 13.08%
Other Investing Activities -$486.4M -$461.8M -$205.4M
YoY Change 5.33% 7470.49% -58.99%
Cash From Investing Activities -$531.7M -$476.1M -$218.4M
YoY Change 11.68% 1696.6% -73.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$2.251B $172.0M $108.7M
YoY Change -1408.49%
Debt Paid & Issued, Net $174.7M $127.2M $302.8M
YoY Change 37.36%
Cash From Financing Activities 2.356B 292.5M 210.4M
YoY Change 705.5% -188.58% -71.67%
NET CHANGE
Cash From Operating Activities 305.1M 254.6M 167.2M
Cash From Investing Activities -531.7M -476.1M -218.4M
Cash From Financing Activities 2.356B 292.5M 210.4M
Net Change In Cash 2.130B 71.00M 159.2M
YoY Change 2899.3% -142.77% 4089.47%
FREE CASH FLOW
Cash From Operating Activities $305.1M $254.6M $167.2M
Capital Expenditures $12.80M $13.60M $11.12M
Free Cash Flow $292.3M $241.0M $156.1M
YoY Change 21.29% 14.11% -62.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
227384000 USD
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
284544000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1008224000 USD
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1035007000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-343901000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-119396000 USD
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
225289000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
267118000 USD
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-21531000 USD
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-13734000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16476000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34308000 USD
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
3475000 USD
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
16449000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16476000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34308000 USD
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7381000 USD
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15156000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5356000 USD
CY2013Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
33279000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
42926000 USD
CY2012Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-391000 USD
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
303598000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
629773000 USD
CY2012Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
211101000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
413770000 USD
CY2012Q4 us-gaap Assets
Assets
17950379000 USD
CY2013Q2 us-gaap Assets
Assets
19782258000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
4532026000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
2777451000 USD
CY2013Q2 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
54400000 USD
CY2012Q4 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
90983000 USD
CY2013Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
0 USD
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
11197000 USD
CY2013Q2 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
0 USD
CY2012Q4 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
11577000 USD
CY2012Q4 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
0 USD
CY2013Q2 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
0 USD
CY2012Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
380000 USD
CY2013Q2 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
0 USD
CY2013Q2 us-gaap Business Acquisition Contingent Consideration At Fair Value Current
BusinessAcquisitionContingentConsiderationAtFairValueCurrent
91029000 USD
CY2012Q4 us-gaap Business Acquisition Contingent Consideration At Fair Value Current
BusinessAcquisitionContingentConsiderationAtFairValueCurrent
102559000 USD
CY2013Q2 us-gaap Business Acquisition Contingent Consideration At Fair Value Noncurrent
BusinessAcquisitionContingentConsiderationAtFairValueNoncurrent
342079000 USD
CY2012Q4 us-gaap Business Acquisition Contingent Consideration At Fair Value Noncurrent
BusinessAcquisitionContingentConsiderationAtFairValueNoncurrent
352523000 USD
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.26
CY2013Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.09
CY2012Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.10
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.10
CY2012Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.10
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.10
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.26
CY2013Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.09
CY2013Q2 us-gaap Business Acquisition Purchase Price Allocation Intangible Assets Not Amortizable
BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable
566501000 USD
CY2012Q4 us-gaap Business Acquisition Purchase Price Allocation Intangible Assets Not Amortizable
BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable
546876000 USD
CY2013Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
27170000 USD
CY2012Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-29840000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-80389000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
29843000 USD
CY2013Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1102521000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
2221497000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
2338044000 USD
CY2012Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1136200000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
15778000 USD
CY2013Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
7879000 USD
CY2012Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
13867000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
21372000 USD
CY2012Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset
7729000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset
1484000 USD
CY2013Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset
3669000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset
17568000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
916091000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2539390000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
330479000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
413736000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
395266000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
164111000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
332455182 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
303861272 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
303861272 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
332455182 shares
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
8250192000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
5940652000 USD
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications and Revision</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior year amounts to conform with the current year presentation.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has revised the consolidated statement of comprehensive loss for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three-month</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">six-month</font><font style="font-family:inherit;font-size:10pt;"> periods ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2012</font><font style="font-family:inherit;font-size:10pt;"> to correct the foreign currency translation adjustment, which resulted in an offsetting adjustment to Goodwill and Intangible assets, net. For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three-month</font><font style="font-family:inherit;font-size:10pt;"> period ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2012</font><font style="font-family:inherit;font-size:10pt;">, the Company increased comprehensive loss by </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$5.1 million</font><font style="font-family:inherit;font-size:10pt;"> with an offsetting decrease in Goodwill and Intangible assets, net. For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">six-month</font><font style="font-family:inherit;font-size:10pt;"> period ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;30, 2012</font><font style="font-family:inherit;font-size:10pt;">, the Company decreased comprehensive loss by </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$16.3 million</font><font style="font-family:inherit;font-size:10pt;"> with an offsetting increase in Goodwill and Intangible assets, net. This revision did not have a material impact to the Company&#8217;s previously reported financial position, results of operations or cash flows. </font></div></div>
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-224160000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-136236000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-241169000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-42806000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-42806000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-241169000 USD
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
192928000 USD
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
283183000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
417124000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
568087000 USD
us-gaap Cost Of Goods Sold Amortization
CostOfGoodsSoldAmortization
0 USD
CY2012Q2 us-gaap Cost Of Goods Sold Amortization
CostOfGoodsSoldAmortization
531000 USD
CY2013Q2 us-gaap Cost Of Goods Sold Amortization
CostOfGoodsSoldAmortization
0 USD
us-gaap Cost Of Goods Sold Amortization
CostOfGoodsSoldAmortization
2557000 USD
CY2012Q2 us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
16839000 USD
CY2013Q2 us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
14459000 USD
us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
29888000 USD
us-gaap Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
104479000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1905598000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1527887000 USD
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
954249000 USD
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
733280000 USD
CY2013Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
4050000000 USD
CY2013Q2 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
198674000 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
195007000 USD
CY2013Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
42331000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
76422000 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
124500000 USD
CY2013Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
123400000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
4403000 USD
CY2013Q2 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
4363000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1248312000 USD
CY2013Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1261125000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
437448000 USD
CY2013Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
317854000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
659299000 USD
CY2012Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
221866000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2012Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-6172000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-10611000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
907000 USD
CY2013Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-3722000 USD
CY2013Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
92800000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M24D
CY2012Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
2882000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3475000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
16449000 USD
CY2013Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
11845000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
3475000 USD
CY2012Q2 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
2882000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
16449000 USD
CY2013Q2 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
11845000 USD
CY2013Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1997626000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2551986000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1204708000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1019292000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1049606000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1101701000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1131581000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11275154000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
10759419000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8761793000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8723168000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-8643000 USD
CY2012Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4238000 USD
CY2013Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-10082000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
20061000 USD
CY2012Q2 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-3299000 USD
CY2013Q2 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-10536000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
22265000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-8766000 USD
CY2012Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1024000 USD
CY2013Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-10551000 USD
CY2013Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
3963000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
2024000 USD
CY2012Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-35000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
5822000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-56779000 USD
CY2013Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1124000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-5572000 USD
CY2012Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-53624000 USD
CY2013Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-21379000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-133000 USD
CY2012Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2012Q4 us-gaap Goodwill
Goodwill
5141366000 USD
CY2013Q2 us-gaap Goodwill
Goodwill
5277798000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
217188000 USD
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
19852000 USD
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-100608000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-30238000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-40345000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-95139000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-17057000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-78475000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-51211000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4290000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4550000 USD
CY2013Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
47375000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-39741000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
56568000 USD
CY2012Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-24156000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
134002000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6603000 USD
CY2013Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
44775000 USD
CY2012Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8183000 USD
CY2013Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
33960000 USD
CY2012Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
16433000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
51513000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
58908000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3133000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5232000 USD
CY2013Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5354000 USD
CY2012Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1133000 USD
CY2013Q2 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
8873000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
CY2012Q2 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
8873000 USD
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2012Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2012Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6294000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9308669000 USD
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9289669000 USD
CY2012Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
100614000 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
332108000 USD
CY2013Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
176793000 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
202639000 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
406018000 USD
CY2013Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
358099000 USD
CY2013Q2 us-gaap Inventory Gross
InventoryGross
555155000 USD
CY2012Q4 us-gaap Inventory Gross
InventoryGross
587287000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
497059000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
531256000 USD
CY2013Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
130306000 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
120885000 USD
CY2013Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
58096000 USD
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
56031000 USD
CY2013Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
66750000 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
60384000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
2143000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
2650000 USD
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1020000 USD
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1054000 USD
CY2013Q2 us-gaap Liabilities
Liabilities
14079729000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
14232981000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17950379000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19782258000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1822752000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1761818000 USD
CY2012Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
103658000 USD
CY2013Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
105766000 USD
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
11015625000 USD
CY2013Q2 us-gaap Long Term Debt
LongTermDebt
10794105000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
480182000 USD
CY2013Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
346875000 USD
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10447230000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10535443000 USD
CY2012Q2 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
-35000 USD
CY2013Q2 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
3963000 USD
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
2024000 USD
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
5822000 USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF BUSINESS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is a multinational, specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical and over-the-counter (&#8220;OTC&#8221;) products, primarily in the areas of eye health, dermatology, neurology and branded generics, as well as medical devices.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 5, 2013, the Company acquired Bausch &amp; Lomb Holdings Incorporated (&#8220;B&amp;L&#8221;), pursuant to an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) dated May 24, 2013. Subject to the terms and conditions set forth in the Merger Agreement, B&amp;L became a wholly-owned subsidiary of Valeant Pharmaceuticals International (&#8220;Valeant&#8221;), a wholly-owned subsidiary of the Company (the &#8220;B&amp;L Acquisition&#8221;). B&amp;L is a global eye health company that focuses primarily on the development, manufacture and marketing of eye health products, including contact lenses, contact lens care solutions, ophthalmic pharmaceuticals and ophthalmic surgical products. For further information regarding the B&amp;L Acquisition, see note 20 titled &#8220;SUBSEQUENT EVENTS AND PENDING TRANSACTIONS&#8221;.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;11, 2012</font><font style="font-family:inherit;font-size:10pt;">, the Company completed the acquisition of Medicis Pharmaceutical Corporation (&#8220;Medicis&#8221;) through a wholly-owned subsidiary pursuant to an Agreement and Plan of Merger, dated as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;2, 2012</font><font style="font-family:inherit;font-size:10pt;">, with Medicis surviving as a wholly-owned subsidiary of the Company (the &#8220;Medicis acquisition&#8221;). For further information regarding the Medicis acquisition, see note 3 titled &#8220;BUSINESS COMBINATIONS&#8221;.</font></div></div>
CY2013Q2 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
2125654000 USD
CY2012Q2 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
64787000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
231155000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
1623299000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
502936000 USD
CY2013Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2356081000 USD
CY2012Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
292498000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1840162000 USD
CY2013Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-531733000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-766629000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-694520000 USD
CY2012Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-476141000 USD
CY2013Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
305028000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
560377000 USD
CY2012Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
254602000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
421832000 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21607000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16664000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-34528000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10866000 USD
us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
46336000 USD
us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
42583000 USD
CY2013Q2 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
5029000 USD
CY2012Q2 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
46336000 USD
CY2013Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segments
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segments
us-gaap Operating Income Loss
OperatingIncomeLoss
258519000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
86810000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
141513000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
148306000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
199436000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
183747000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-1000 USD
CY2013Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-13000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2560000 USD
CY2012Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
78000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
201000 USD
CY2012Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-202692000 USD
CY2013Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-141058000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-224126000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-6647000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-224126000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8278000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-224505000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-8278000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-224505000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-147102000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-202553000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
-3964000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3584000 USD
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
161711000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
170293000 USD
CY2012Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
60000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2644000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
7673000 USD
CY2013Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3609000 USD
CY2013Q2 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
11728000 USD
us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
14548000 USD
CY2012Q2 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
1752000 USD
us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
1812000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
280724000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
55629000 USD
CY2013Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
20624000 USD
CY2012Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
172000000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2542000 USD
CY2012Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1107000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
33636000 USD
CY2013Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
325000 USD
CY2013Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
30500000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
21531000 USD
CY2012Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9910000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
13734000 USD
CY2013Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14683000 USD
CY2013Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
513457000 USD
CY2012Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
454020000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
726832000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
751060000 USD
CY2013Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
32509000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
33216000 USD
CY2012Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
695000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26803000 USD
CY2012Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13601000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24717000 USD
CY2013Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12761000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2013Q2 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
7200000 USD
CY2012Q2 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
115497000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
130279000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2271250000 USD
CY2013Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2271250000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2012Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2013Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
340000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
340000000 USD
CY2012Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
640767000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1286410000 USD
CY2013Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
7993000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
9412000 USD
CY2012Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1048000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
17020000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
27430000 USD
CY2013Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
19001000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
66250000 USD
CY2012Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
19600000 USD
CY2012Q2 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
12236000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
18642000 USD
CY2013Q2 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
14171000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7019000 USD
CY2012Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1911000 USD
CY2013Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1894000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4571000 USD
us-gaap Profit Loss
ProfitLoss
479308000 USD
CY2012Q2 us-gaap Profit Loss
ProfitLoss
231728000 USD
us-gaap Profit Loss
ProfitLoss
410418000 USD
CY2013Q2 us-gaap Profit Loss
ProfitLoss
265498000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
440998000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
462724000 USD
CY2013Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
1127006000 USD
CY2012Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
913835000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
3975000 USD
CY2012Q2 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2013Q2 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2013Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
174707000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
604743000 USD
CY2012Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
127181000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
429993000 USD
CY2013Q2 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
10855000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
12272000 USD
CY2012Q2 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
21582000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
21582000 USD
CY2013Q2 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
18327000 USD
CY2012Q2 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
20249000 USD
us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
38557000 USD
us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
46241000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
48264000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
39717000 USD
CY2013Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
24469000 USD
CY2012Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
17711000 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
4568000 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
4830000 USD
CY2013Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
4830000 USD
CY2012Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
4568000 USD
us-gaap Restructuring Charges
RestructuringCharges
102650000 USD
CY2013Q2 us-gaap Restructuring Charges
RestructuringCharges
53665000 USD
us-gaap Restructuring Charges
RestructuringCharges
92341000 USD
CY2012Q2 us-gaap Restructuring Charges
RestructuringCharges
30004000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2429051000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2370976000 USD
CY2013Q2 us-gaap Revenues
Revenues
1095762000 USD
us-gaap Revenues
Revenues
1676193000 USD
us-gaap Revenues
Revenues
2164117000 USD
CY2012Q2 us-gaap Revenues
Revenues
820090000 USD
CY2012Q2 us-gaap Royalty Revenue
RoyaltyRevenue
56869000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
136100000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
23180000 USD
CY2013Q2 us-gaap Royalty Revenue
RoyaltyRevenue
13922000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1493852000 USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1063513000 USD
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
742972000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2102380000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
257373000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
185440000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
362726000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
499272000 USD
CY2012Q2 us-gaap Share Based Compensation
ShareBasedCompensation
15156000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
16476000 USD
CY2013Q2 us-gaap Share Based Compensation
ShareBasedCompensation
7381000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
34308000 USD
CY2013Q2 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
13300000 USD
CY2013Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
27058824 shares
CY2013Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2300000000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2269470000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1065000 USD
CY2012Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3634506000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3717398000 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3929830000 USD
CY2013Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
200000 USD
CY2013Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
25500000 USD
CY2013Q2 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
1000000 USD
CY2013Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
92000000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7019000 USD
CY2013Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
7706 shares
CY2013Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
225000 shares
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
280724000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
55629000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
5702529000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
3717398000 USD
CY2013Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5702529000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In preparing the unaudited consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the dates of the unaudited consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates and the operating results for the interim periods presented are not necessarily indicative of the results expected for the full&#160;year.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;padding-left:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company&#8217;s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company&#8217;s results of operations and financial position could be materially impacted.</font></div></div>
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
307677000 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
304816000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
306296000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
314447000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
304816000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
307677000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
306296000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
308153000 shares
vrx Acquisition Accounting Adjustment On Inventory Sold
AcquisitionAccountingAdjustmentOnInventorySold
43392000 USD
CY2013Q2 vrx Acquisition Accounting Adjustment On Inventory Sold
AcquisitionAccountingAdjustmentOnInventorySold
26518000 USD
vrx Acquisition Accounting Adjustment On Inventory Sold
AcquisitionAccountingAdjustmentOnInventorySold
69759000 USD
CY2012Q2 vrx Acquisition Accounting Adjustment On Inventory Sold
AcquisitionAccountingAdjustmentOnInventorySold
10294000 USD
CY2012Q2 vrx Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
1720000 USD
CY2013Q2 vrx Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
11576000 USD
vrx Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
20570000 USD
vrx Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
6103000 USD
vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
411213000 USD
CY2012Q2 vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
210570000 USD
vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
629773000 USD
CY2013Q2 vrx Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
303598000 USD
vrx Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value
BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue
126028000 USD
CY2012Q2 vrx Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value
BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue
108284000 USD
CY2013Q2 vrx Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value
BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue
8291000 USD
vrx Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value
BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue
67355000 USD
vrx Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold
BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold
67900000 USD
CY2013Q2 vrx Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold
BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold
26400000 USD
CY2013Q2 vrx Business Acquisition Pro Forma Acquisition Related Costs
BusinessAcquisitionProFormaAcquisitionRelatedCosts
4300000 USD
vrx Business Acquisition Pro Forma Acquisition Related Costs
BusinessAcquisitionProFormaAcquisitionRelatedCosts
10100000 USD
vrx Business Acquisition Purchase Price Allocation Current Assets Inventory Adjustment
BusinessAcquisitionPurchasePriceAllocationCurrentAssetsInventoryAdjustment
69800000 USD
CY2013Q2 vrx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
3669000 USD
vrx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
1484000 USD
vrx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
17568000 USD
CY2012Q2 vrx Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
7729000 USD
CY2013Q2 vrx Deferred Compensation Arrangementwith Individual Compensation Expense Increase Decrease Reclassificationof Award
DeferredCompensationArrangementwithIndividualCompensationExpenseIncreaseDecreaseReclassificationofAward
21300000 USD
CY2012Q2 vrx Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-5850000 USD
CY2013Q2 vrx Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-63220000 USD
vrx Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-100575000 USD
vrx Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-20709000 USD
CY2012Q4 vrx Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
11306295000 USD
CY2013Q2 vrx Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
11841655000 USD
vrx Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax
0 USD
vrx Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax
1000 USD
CY2012Q2 vrx Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax
0 USD
CY2013Q2 vrx Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax
0 USD
vrx Other Comprehensive Income Reclassification Adjustment For Debt Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForDebtSecuritiesNetOfTax
0 USD
CY2012Q2 vrx Other Comprehensive Income Reclassification Adjustment For Debt Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForDebtSecuritiesNetOfTax
-197000 USD
vrx Other Comprehensive Income Reclassification Adjustment For Debt Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForDebtSecuritiesNetOfTax
-197000 USD
CY2013Q2 vrx Other Comprehensive Income Reclassification Adjustment For Debt Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForDebtSecuritiesNetOfTax
0 USD
CY2013Q2 vrx Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax
3963000 USD
CY2012Q2 vrx Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax
0 USD
vrx Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax
1634000 USD
vrx Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax
3963000 USD
CY2013Q2 vrx Payments Of Contingent Consideration
PaymentsOfContingentConsideration
61885000 USD
vrx Potential Weighted Average Number Of Diluted Shares Outstanding
PotentialWeightedAverageNumberOfDilutedSharesOutstanding
314514000 shares
CY2012Q2 vrx Potential Weighted Average Number Of Diluted Shares Outstanding
PotentialWeightedAverageNumberOfDilutedSharesOutstanding
312631000 shares
vrx Potential Weighted Average Number Of Diluted Shares Outstanding
PotentialWeightedAverageNumberOfDilutedSharesOutstanding
314118000 shares
vrx Repurchase Of Equity Component Of Convertible Debt
RepurchaseOfEquityComponentOfConvertibleDebt
2862000 USD
CY2013Q2 vrx Saleof Stock Public Offering Price Per Share
SaleofStockPublicOfferingPricePerShare
85.00
vrx Other Comprehensive Income Unrealized Holding Gain Loss On Debt Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnDebtSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2013Q2 vrx Other Comprehensive Income Unrealized Holding Gain Loss On Debt Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnDebtSecuritiesArisingDuringPeriodNetOfTax
0 USD
vrx Other Comprehensive Income Unrealized Holding Gain Loss On Debt Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnDebtSecuritiesArisingDuringPeriodNetOfTax
7000 USD
CY2012Q2 vrx Other Comprehensive Income Unrealized Holding Gain Loss On Debt Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnDebtSecuritiesArisingDuringPeriodNetOfTax
20000 USD
CY2012Q2 vrx Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2013Q2 vrx Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax
-2094000 USD
vrx Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax
3584000 USD
vrx Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2013Q2 vrx Payment Of Accreted Interest On Contingent Consideration
PaymentOfAccretedInterestOnContingentConsideration
2234000 USD
CY2012Q2 vrx Payment Of Accreted Interest On Contingent Consideration
PaymentOfAccretedInterestOnContingentConsideration
898000 USD
vrx Payment Of Accreted Interest On Contingent Consideration
PaymentOfAccretedInterestOnContingentConsideration
2872000 USD
vrx Payment Of Accreted Interest On Contingent Consideration
PaymentOfAccretedInterestOnContingentConsideration
898000 USD
vrx Payments Of Contingent Consideration
PaymentsOfContingentConsideration
61018000 USD
CY2012Q2 vrx Payments Of Contingent Consideration
PaymentsOfContingentConsideration
33518000 USD
vrx Payments Of Contingent Consideration
PaymentsOfContingentConsideration
82939000 USD
CY2013Q2 vrx Sharebased Compensation Expense Increase Decrease Reclassificationof Award
SharebasedCompensationExpenseIncreaseDecreaseReclassificationofAward
5800000 USD
CY2013Q2 vrx Stockholders Equity Before Comprehensive Income Net Of Tax
StockholdersEquityBeforeComprehensiveIncomeNetOfTax
5943698000 USD
CY2012Q2 vrx Stockholders Equity Before Comprehensive Income Net Of Tax
StockholdersEquityBeforeComprehensiveIncomeNetOfTax
3677312000 USD
CY2013Q2 vrx Unrecognized Tax Benefits Including Interest And Penalties
UnrecognizedTaxBenefitsIncludingInterestAndPenalties
131400000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000885590
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
333524295 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Valeant Pharmaceuticals International, Inc.

Files In Submission

Name View Source Status
0000885590-13-000067-index-headers.html Edgar Link pending
0000885590-13-000067-index.html Edgar Link pending
0000885590-13-000067.txt Edgar Link pending
0000885590-13-000067-xbrl.zip Edgar Link pending
exhibit103.htm Edgar Link pending
exhibit104.htm Edgar Link pending
exhibit105.htm Edgar Link pending
exhibit106.htm Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R45.xml Edgar Link unprocessable
R46.htm Edgar Link pending
R46.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R47.xml Edgar Link unprocessable
R48.htm Edgar Link pending
R48.xml Edgar Link unprocessable
R49.htm Edgar Link pending
R49.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R50.htm Edgar Link pending
R50.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R51.xml Edgar Link unprocessable
R52.htm Edgar Link pending
R52.xml Edgar Link unprocessable
R53.htm Edgar Link pending
R53.xml Edgar Link unprocessable
R54.htm Edgar Link pending
R54.xml Edgar Link unprocessable
R55.htm Edgar Link pending
R55.xml Edgar Link unprocessable
R56.htm Edgar Link pending
R56.xml Edgar Link unprocessable
R57.htm Edgar Link pending
R57.xml Edgar Link unprocessable
R58.htm Edgar Link pending
R58.xml Edgar Link unprocessable
R59.htm Edgar Link pending
R59.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R60.htm Edgar Link pending
R60.xml Edgar Link unprocessable
R61.htm Edgar Link pending
R61.xml Edgar Link unprocessable
R62.htm Edgar Link pending
R62.xml Edgar Link unprocessable
R63.htm Edgar Link pending
R63.xml Edgar Link unprocessable
R64.htm Edgar Link pending
R64.xml Edgar Link unprocessable
R65.htm Edgar Link pending
R65.xml Edgar Link unprocessable
R66.htm Edgar Link pending
R66.xml Edgar Link unprocessable
R67.htm Edgar Link pending
R67.xml Edgar Link unprocessable
R68.htm Edgar Link pending
R68.xml Edgar Link unprocessable
R69.htm Edgar Link pending
R69.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R70.htm Edgar Link pending
R70.xml Edgar Link unprocessable
R71.htm Edgar Link pending
R71.xml Edgar Link unprocessable
R72.htm Edgar Link pending
R72.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
valeantq22013.htm Edgar Link pending
vrx-20130630.xml Edgar Link completed
vrx-20130630.xsd Edgar Link pending
vrx-20130630_cal.xml Edgar Link unprocessable
vrx-20130630_def.xml Edgar Link unprocessable
vrx-20130630_lab.xml Edgar Link unprocessable
vrx-20130630_pre.xml Edgar Link unprocessable